Viewing Study NCT01565434



Ignite Creation Date: 2024-05-06 @ 12:23 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01565434
Status: COMPLETED
Last Update Posted: 2016-06-09
First Post: 2012-03-26

Brief Title: Erythrocyte Complement Receptor 1 and Alzheimer Disease
Sponsor: CHU de Reims
Organization: CHU de Reims

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2012-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Main objective investigate whether a functional polymorphism of CR1 length number of binding sites in C4b C3b erythrocyte density rate of soluble CR1 so determined genetic or acquired is a susceptibility factor for the disease Alzheimers
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None